Lissencephaly and Periventricular Heterotopia
Lissencephaly (LIS)
LIS is a neuronal migration disorder and represents a malformation spectrum resulting from mutations of either LIS1 or DCX genes. In severe LIS, the cortex lacks surface folds. At the same time, manifestations include abnormally broad folds or a heterotopic layer of gray matter embedded in the white matter below the cortex.
Fig.1 The classical lissencephaly spectrum. (Fry, 2014)
Key Factors for LIS
Malformation syndromes such as LIS have been recognized, and specific causative gene defects have been identified in recent years. Five genes have been identified that cause or contribute to LIS in humans: LIS1, DCX, RELN, ARX, and TUBA1A.
LIS1 | The LIS1 gene is the first gene associated with LIS, and its mutations cause severe malformation posteriorly. |
DCX | DCX (also known as XLIS) is the second major gene associated with LIS. DCX mutations can cause the spectrum of LIS in males. Women with this mutation classically have a migration disorder called SBH. |
RELN | The gene encoding the receptor for RELN, a very low-density lipoprotein receptor (VLDLR), is also shown to be causative for LIS. In patients, Autosomal recessive LIS, accompanied by severe delay, cerebellar hypoplasia, and seizures, is associated with mutations of RELN. |
ARX | ARX mutations cause a series of neurologic diseases, such as LIS with anomalous genitalia and severe epilepsy. |
TUBA1A | TUBA1A is also a causative gene for LIS disease. Patients with TUBA1A mutations have many additional defects that are less commonly associated with LIS1 and DCX mutations, such as hypoplasia of the anterior limb of the internal capsule. |
Fig.2 Genetic heterogeneity in lissencephaly. (Fry, 2014)
Periventricular Heterotopia
Periventricular nodular heterotopia (PH) is a heterogeneous group of malformations in which more profound heterotopic neurons are observed. PH features the subset of neurons that line the walls of lateral ventricles after failing to migrate completely into the cerebral cortex.
This malformation may involve both sides of the brain or be restricted to a single hemisphere less frequently. They can occur singly or combined with other findings, including polymicrogyria, microcephaly, hydrocephalus, and limb abnormalities. PH can be caused by genetic mutations (e.g., FilaminA, ARFGEF2) or extrinsic factors (e.g., irradiation, infection, injury). Seizures are the most common presenting feature.
Key Factors for PH
PH is caused by genetic mutations or extrinsic factors, such as infections or prenatal injuries; PH has previously been identified with amniotic band syndrome in some clinical cases. Two genes are already known to cause PH: filaminA (FLNA) and adenosine diphosphate-ribosylation factor guanine exchange factor 2 (ARFGEF2). FLNA mutations are reported in all familial X-linked PH and approximately 25% of sporadic cases. Rare patients of both genders with FLN1 mutations had unilateral PH. In addition, patients with mutations of the ARFGEF2 gene present microcephaly, slightly enlarged ventricles, and delayed myelination. The X-linked dominant form of PH is caused by mutations in FLNA, whereas mutations cause the autosomal recessive form of PH and microcephaly in ARFGEF2.
Fig.3 Representative MRI section of PH in a patient with FILNA mutations. (Nadia Bahi-Buisson, 2013)
Products Provided by Creative Biolabs
Creative Biolabs has hugely experienced specialists working alongside our teams, providing expert advice and an enormous breadth of advanced technologies. Our high-quality products and services include vectors, cell lines, proteins & peptides, and antibodies, and animal models for your research. The LIS and PH related products are as following:
DCX | RELN | VLDLR |
LIS1 | ARX | TUBA1A |
To see more detailed information on our products, please directly send us your inquiry.
References
- Fry, A. E.; et al. The genetics of lissencephaly. In American Journal of Medical Genetics Part C: Seminars in Medical Genetics (Vol. 166, No. 2, pp. 198-210). 2014, June.
- Bahi-Buisson, N.; Guerrini, R. Diffuse malformations of cortical development. Handbook of clinical neurology. 2013, 111, 653-665.
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-CD32b Antibody(NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- NeuroMab™ Anti-TREM2 Antibody(NRP-0422-P792) (Cat#: NRP-0422-P792)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody(NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- NeuroMab™ Anti-GARP Antibody(NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- NeuroMab™ Anti-F-Spondin/SPON1 Antibody, Clone N24875P (CBP11839) (Cat#: NRZP-0822-ZP4740)
- NeuroMab™ Anti-Amyloid Beta 1-15 Antibody(NRP-0422-P867) (Cat#: NRP-0422-P867)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Green Fluorescent Alpha-synuclein SH-SY5Y Cell Line (Cat#: NCL2110P209)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- AAV-EF1a-mCherry-flex-dtA (Cat#: NRZP-0622-ZP616)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)